Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?
Despite the availability of effective and inexpensive hormonal contraceptives, many women risk unintended pregnancies because of medical contraindications, or serious unpleasant or unbearable side-effects associated with the use of exogenous hormones.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
GO Prime with only $1.49 now
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




